patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: A reason for the steady price lately.

December 9, 2011

7:33a
Pluristem Therapeutics Started At Spec Buy By Global Hunter Securities >PSTI (Dow Jones
Share
New Message
Please login to post a reply